Renovacor (RCOR) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 78 244 sessions, November 30, 2021 to November 30, 2022
- Largest daily move
- -21.6% close of May 10, 2022
- 1-year change
- -63.6% closing prices, November 30, 2021 to November 30, 2022
- 1-month change
- +4.6% closing prices, October 28, 2022 to November 30, 2022
Company Description
Renovacor (NYSE: RCOR) is classified in the biotechnology industry within the Healthcare sector.
RCOR has declined 63.6% over the past year. The last closing price was $3.20.
This page collects what Stock Titan holds for RCOR, including price data and latest news.
Stock Performance
Renovacor (RCOR) closed at $3.20 on November 30, 2022. Over the past 12 months, the price has lost 63.6%.
RCOR Metrics & Rankings
Price returns through November 30, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Renovacor has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include management, acquisition, conferences, earnings. View all RCOR news →
SEC Filings
RCOR Company Profile & Sector Positioning
Renovacor (RCOR) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NYSE.
Investors comparing RCOR often look at related companies in the same sector, including Karyopharm Therapeutics Inc. (KPTI), Liminatus Pharma, Inc. (LIMN), Sigilon Therapeutics, Inc. (SGTX), MAIA Biotechnology, Inc. (MAIA), and CAMP4 Therapeutics Corporation (CAMP). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate RCOR's relative position within its industry.